Flexion Therapeutics Named Top Place to Work for 2017 by The Boston Globe
November 17 2017 - 09:00AM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it
has been named one of the Top Places to Work in Massachusetts in
the 10th annual employee-based survey project conducted by The
Boston Globe. The Top Places to Work 2017 will be published in The
Boston Globe Magazine on November 19, and the results can also be
found online at www.globe.com/topplaces.
The survey identifies and recognizes top workplaces through
confidential employee opinions about their company’s direction,
execution, connection, management, work, pay and benefits, and
engagement. Flexion ranked 11th out of 25 in the small company
category which includes organizations that had 50 to 99 employees
at the time of the survey.
“We are truly honored to receive this award, which is really a
reflection of our employees,” said Michael Clayman, M.D., President
and Chief Executive Officer of Flexion. “Our people are the
foundation of Flexion’s success, and it is a privilege to lead this
remarkable team. They are the reason that Flexion is such a special
place to work.”
Flexion is distinguished by five core values that define its
culture – focus, ingenuity, tenacity, transparency and fun. These
values serve as the pillars upon which co-founders, Dr. Clayman and
Neil Bodick, M.D., Ph.D., Chief Scientific Officer, established and
grew Flexion.
“Our winning companies are all in on a secret,” said Katie
Johnston, The Globe’s Top Places to Work editor. “Treating
employees well isn’t that difficult, and the payoff -- increased
morale, retention, and productivity -- is huge.”
The rankings in the Top Places to Work are based on confidential
survey information collected by Energage (formerly
WorkplaceDynamics), an independent company specializing in employee
engagement and retention, from nearly 75,060 individuals at 334
Massachusetts organizations. The winners share a few key traits,
including offering progressive benefits, ensuring their employees
have a voice, and encouraging them to have some fun while doing
important work.
About Flexion Therapeutics Flexion Therapeutics
(Nasdaq:FLXN) is a specialty pharmaceutical company focused on the
development and commercialization of novel, local therapies for the
treatment of patients with musculoskeletal conditions, beginning
with OA, a type of degenerative arthritis. The company's core
values are focus, ingenuity, tenacity, transparency and fun.
Flexion was named one of the Boston Business
Journal's 2017 Best Places to Work.
About Boston Globe Media Partners
LLC
Boston Globe Media Partners, LLC provides news and information,
entertainment, opinion and analysis through its multimedia
properties. BGMP includes the Boston Globe, BostonGlobe.com,
Boston.com, STAT and Globe Direct.
Contacts:
Scott YoungSr. Director, Corporate Communications & Investor
RelationsFlexion Therapeutics, Inc.T:
781-305-7194syoung@flexiontherapeutics.com
Julie DownsManager, Corporate CommunicationsFlexion
Therapeutics, Inc.T:
781-305-7137jdowns@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Mar 2023 to Mar 2024